Abstract Background Neutralizing antibodies (NAbs) prevent pathogens from infecting host
cells. Detection of SARS-CoV-2 NAbs is critical to evaluate herd immunity and monitor …

The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need
for highly effective vaccine candidates that are thermostable and amenable to large-scale …

The COVID‐19 pandemic, caused by the SARS‐CoV‐2 coronavirus, has triggered a
worldwide health emergency. Here, we show that ferritin‐like Dps from hyperthermophilic …

Vaccines that induce potent neutralizing antibody (NAb) responses against emerging
variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are essential for …

Prevention of COVID‐19 on a global scale will require the continued development of high‐
volume, low‐cost platforms for the manufacturing of vaccines to supply ongoing demand …

Currently, SARS-CoV-2 spike receptor-binding-domain (RBD)-based vaccines are
considered one of the most effective weapons against COVID-19. During the first step of …

The speed at which several COVID-19 vaccines went from conception to receiving FDA and
EMA approval for emergency use is an achievement unrivaled in the history of vaccine …

Vaccines against SARS-CoV-2 have been distributed at massive scale in developed
countries, and have been effective at preventing COVID-19. Access to vaccines is limited …

Global deployment of vaccines that can provide protection across several age groups is still
urgently needed to end the COVID-19 pandemic especially for low-and middle-income …

The SARS-CoV-2 virus spike protein, specifically its receptor binding domain (RBD), has
emerged as a promising target for generation of neutralizing antibodies. Although the RBD …